Merck KGaA sticks with China strategy despite geopolitical tensions
reuters.com
news
2022-10-20 12:20:57

A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph OrlowskiFRANFURT/LONDON, Oct 20 (Reuters) - Merck KGaA's (MRCG.DE) investment strategy in China has not changed despite rising geopolitical tensions, but the German healthcare and chip materials maker is "mindful of the potential risks", its CEO told Reuters on Thursday.China is key region for the semiconductor industry and drug companies, including Merck, but geopolitical challenges are growing.
